Steve Jobs’s son tackles cancer with new firm, Yosemite

Investors in the first close for Yosemite's debut fund include Emerson Collective, The Rockefeller University, Memorial Sloan Kettering Cancer Center and venture capitalist John Doerr.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.